FIELD: biotechnology.
SUBSTANCE: method for culturing regulatory T cells is proposed, which includes culturing isolated regulatory T cells in a medium containing a fusion protein dimer. Said fusion protein dimer contains IL-2 protein or a variant thereof and CD80 protein or a fragment thereof.
EFFECT: invention increases the efficiency of proliferation and viability of the resulting Foxp3+ regulatory T cells.
9 cl, 41 dwg, 14 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POLYVALENT MODULATORS OF REGULATORY T-CELLS | 2017 |
|
RU2769871C2 |
| PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF HEPATITIS, LIVER FIBROSIS AND LIVER CIRRHOSIS, INCLUDING FUSION PROTEINS | 2017 |
|
RU2795548C2 |
| MULTIFUNCTIONAL MULTI-SPECIFIC MULTIMERIC BIOMOLECULAR POLYMER WITH PROLONGED IN VIVO EFFICIENCY | 2020 |
|
RU2805307C1 |
| PROTEINS WITH A DOUBLE FUNCTION AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2016 |
|
RU2741345C2 |
| COMPOSITION FOR RELIEVING OR TREATING PAIN | 2017 |
|
RU2725830C1 |
| MODIFIED Α1-Α2 DOMAINS OF NON-NATURAL NKG2D LIGANDS THAT BIND TO NON-NATURAL NKG2D RECEPTORS | 2019 |
|
RU2815278C2 |
| MODIFIED MITOCHONDRIA AND THEIR USE | 2019 |
|
RU2811467C2 |
| COMPOSITION FOR CULTURING NATURAL KILLER CELLS AND METHOD OF PRODUCING NATURAL KILLER CELLS USING SAME | 2020 |
|
RU2824216C1 |
| ANTI-LILRB1 ANTIBODY AND USES THEREOF | 2021 |
|
RU2813373C1 |
| MODIFIED NON-NATURAL NKG2D LIGANDS WHICH SELECTIVELY DELIVER ATTACHED HETEROLOGOUS MOLECULES TO NON-NATURAL NKG2D RECEPTORS ON CAR CELLS | 2020 |
|
RU2823728C2 |
